정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2403 | Recruiting | A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes | Acute Respiratory Distress Syndrome | Drug: LEAF-4L6715 | Phase 2 | Institut de cancerologie Strasbourg Europe, LEAF4Life, Inc. | OTHER | 90 | All | 18 Years | Hopitaux Universitaires de Strasbourg, Strasbourg, France Institut de cancerologie Strasbourg Europe, Strasbourg, France |
| 2402 | Terminated | A Study of LY3127804 in Participants With COVID-19 | Pneumonia | Drug: LY3127804 Drug: Placebo |
Phase 2 | Eli Lilly and Company | INDUSTRY | 95 | All | 18 Years | Banner Univ Med Ctr Phoenix, Phoenix, Arizona, United States Banner Univ Med Ctr Tucson, Tucson, Arizona, United States National Jewish Medical and Research Center, Denver, Colorado, United States Nuvance Danbury Hospital, Danbury, Connecticut, United States NorthShore University HealthSystem, Evanston, Illinois, United States Parkview Research Center, Fort Wayne, Indiana, United States Franciscan St. Francis Health, Indianapolis, Indiana, United States Ochsner Clinic Foundation, New Orleans, Louisiana, United States Lahey Hospital and Medical Center, Burlington, Massachusetts, United States Henry Ford Hospital Detroit, Detroit, Michigan, United States Allina Hospital Network, Minneapolis, Minnesota, United States State University of New York Hospital, Syracuse, New York, United States East Carolina University, Greenville, North Carolina, United States |
| 2401 | Active, not recruiting | A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness | COVID-19 | Drug: LY3819253 Drug: LY3832479 Drug: Placebo |
Phase 3 | Eli Lilly and Company, AbCellera Biologics Inc., Shanghai Junshi Bioscience Co., Ltd. | INDUSTRY | 3290 | All | University of Alabama at Birmingham, Birmingham, Alabama, United States Arizona Clin Trials-Mesa, Mesa, Arizona, United States Perseverance Research Center, Scottsdale, Arizona, United States CRI of Arizona, LLC, Sun City West, Arizona, United States Fiel Family and Sports Medicine PC, Tempe, Arizona, United States Orange Grove Banner Clinic, Tucson, Arizona, United States Arizona Clin Trials-Tucson, Tucson, Arizona, United States Arkansas Children's, Little Rock, Arkansas, United States KLR Business Group, Inc. dba Arkansas Clinical Research, Little Rock, Arkansas, United States Applied Rsch Ctr - Arkansas Inc., Little Rock, Arkansas, United States Smart Cures Clin Research, Anaheim, California, United States Hope Clinical Research, Canoga Park, California, United States VCT-Covina, Covina, California, United States AMCR Institute, Escondido, California, United States Chemidox Clinical Trials, Lancaster, California, United States Ark Clinical Research, Long Beach, California, United States Long Beach Clinical Trials LLC, Long Beach, California, United States Cedars Sinai Medical Center, Los Angeles, California, United States UCLA Mattel Children's Hospital, Los Angeles, California, United States Central Valley Research, LLC, Modesto, California, United States Catalina Research Institute, LLC, Montclair, California, United States Inland Empire Liver Foundation, Rialto, California, United States Sutter Institute For Medical Research, Sacramento, California, United States Zion Medical Center, San Diego, California, United States Kaiser Permanente - SD Med Ctr, San Diego, California, United States Wolverine Clinical Trials, LLC, Santa Ana, California, United States St. Joe Heritage HC-Santa Rosa, Santa Rosa, California, United States Stanford University Hospital, Stanford, California, United States Mazur, Statner, Dutta, Nathan, Thousand Oaks, California, United States South Bay Clinical Research Institute, Torrance, California, United States Infect Disease Doctors Med Grp, Walnut Creek, California, United States Allianz Research Institute, Westminster, California, United States Future Innovative Treatments LLC, Colorado Springs, Colorado, United States Nemours Childrens Clinic - Delaware Valley of The Nemours Foundation, Wilmington, Delaware, United States Georgetown Univ Sch of Med, Washington, District of Columbia, United States Synergy Healthcare LLC, Bradenton, Florida, United States Holy Cross Hospital Inc., Fort Lauderdale, Florida, United States I R & Health Center, Inc., Hialeah, Florida, United States Encore Medical Research, Hollywood, Florida, United States Elixia CRC, Hollywood, Florida, United States University of Florida Jacksonville, Jacksonville, Florida, United States Lakeland Regional Medical Center, Lakeland, Florida, United States Panax Clinical Research, Miami Lakes, Florida, United States Hope Clinical Trials, Inc., Miami, Florida, United States Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States Bio-Medical Research, LLC, Miami, Florida, United States Clinical Site Partners, LLC d/b/a CSP Miami, Miami, Florida, United States GCPR, Saint Petersburg, Florida, United States Testing Matters Lab, Sunrise, Florida, United States Advent Health Tampa, Tampa, Florida, United States Triple O Research Inst, West Palm Beach, Florida, United States Encore Medical Research - Weston, Weston, Florida, United States Clinical Site Partners, LLC DBA CSP Orlando, Winter Park, Florida, United States Gwinnett Research Inst, Buford, Georgia, United States Paramount Rch Sol - College Pk, College Park, Georgia, United States IACT Health - VHC, Columbus, Georgia, United States Central Georgia Infectious Disease, Macon, Georgia, United States Rophe Adult and Pediatric Medicine, Union City, Georgia, United States Rocky Mountain Clinical Research, Idaho Falls, Idaho, United States Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, United States Northwestern University, Chicago, Illinois, United States J H. Stroger Hosp of Cook Co, Chicago, Illinois, United States University of Chi Med Center, Chicago, Illinois, United States Great Lakes Clinical Trials - Andersonville, Chicago, Illinois, United States Franciscan Health Hammond, Dyer, Indiana, United States Qualmedica Research Evansville, Evansville, Indiana, United States Community Hospital South, Indianapolis, Indiana, United States Franciscan St. Francis Health, Indianapolis, Indiana, United States St.Vincent - Indy, Indianapolis, Indiana, United States University of Louisville, Louisville, Kentucky, United States Qualmedica Research, LLC, Owensboro, Kentucky, United States Tandem Clinical Research,LLC, Marrero, Louisiana, United States Imperial Health Urgent Care Center - Moss Bluff, Moss Bluff, Louisiana, United States Nola Research Works, LLC, New Orleans, Louisiana, United States University of Maryland Medical Center, Baltimore, Maryland, United States Institute for Advanced Clinical Trials for Children, Rockville, Maryland, United States Massachusetts General Hospital, Boston, Massachusetts, United States U of MA Mem Med Ctr, Worcester, Massachusetts, United States University of Michigan Health Systems, Ann Arbor, Michigan, United States Great Lakes Research Group, Inc., Bay City, Michigan, United States Childrens Hospital of Michigan, Detroit, Michigan, United States Henry Ford Hospital, Detroit, Michigan, United States Revive Research Institute, Farmington Hills, Michigan, United States Revival Research Institute, Sterling Heights, Michigan, United States Sky Clinical Prime and Health Wellness Clinic, Fayette, Mississippi, United States University of Mississippi Medical Center, Jackson, Mississippi, United States Olive Branch Family Medical Center, Olive Branch, Mississippi, United States Sky Clin Resch - Quinn HC, Ridgeland, Mississippi, United States Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States Be Well Clinical Studies, Lincoln, Nebraska, United States Childrens Endocrine Clinic, Omaha, Nebraska, United States Quality Clinical Research, Omaha, Nebraska, United States Excel Clinical Research, Las Vegas, Nevada, United States Las Vegas Medical Research, Las Vegas, Nevada, United States SG Clinical Research - PC, Las Vegas, Nevada, United States Robert Wood Johnson University Medical School, New Brunswick, New Jersey, United States Holy Name Medical Center, Teaneck, New Jersey, United States Care Access Research - Bronx, Bronx, New York, United States Icahn Sch of Med at Mt. Sinai, New York, New York, United States University of North Carolina, Chapel Hill, North Carolina, United States OnSite Clinical Solutions, Charlotte, North Carolina, United States East Carolina University, Greenville, North Carolina, United States Monroe Biomed Research, Monroe, North Carolina, United States Carteret Medical Group, Morehead City, North Carolina, United States Carolina Research Center, Inc., Shelby, North Carolina, United States PMG Research of Wilmington, Wilmington, North Carolina, United States Valley Medical Primary Care, Centerville, Ohio, United States Hometown UC and Rch- Cincy, Cincinnati, Ohio, United States Cleveland Clinic Foundation, Cleveland, Ohio, United States OH State Univ College of Med, Columbus, Ohio, United States Aventiv Research Inc, Columbus, Ohio, United States Urgent Care Specialists, LLC, Columbus, Ohio, United States Remington-Davis, Inc, Columbus, Ohio, United States Urgent Care Specialists, LLC, Dayton, Ohio, United States META Medical Research Institute, Dayton, Ohio, United States Ascension St. John Tulsa OK, Tulsa, Oklahoma, United States Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States Jefferson Hosp for Neurosci, Philadelphia, Pennsylvania, United States Temple University Hospital, Philadelphia, Pennsylvania, United States Hasbro Children's Hospital, Providence, Rhode Island, United States VITALINK - Anderson, Anderson, South Carolina, United States Carolina Medical Research - Clinton, Clinton, South Carolina, United States VITALINK - Gaffney, Gaffney, South Carolina, United States Carolina Medical Research - Greenville, Greenville, South Carolina, United States VITALINK - Greenville, Greenville, South Carolina, United States VITALINK - Spartanburg, Spartanburg, South Carolina, United States VITALINK - Union, Union, South Carolina, United States Univ Diab & Endo Consult, Chattanooga, Tennessee, United States New Phase Research and Development, Knoxville, Tennessee, United States St Jude Childrens Research Hospital, Memphis, Tennessee, United States Gadolin Research, LLC, Beaumont, Texas, United States Conroe Willis Medical Research, Conroe, Texas, United States Driscoll Children's Hospital, Corpus Christi, Texas, United States Crossroads Clinical Research, Corpus Christi, Texas, United States B S & W Med Center, Dallas, Texas, United States Baylor - Fort Worth, Fort Worth, Texas, United States North Texas Clinical Trials, LLC, Fort Worth, Texas, United States Houston Methodist Research Ins, Houston, Texas, United States Next Level Urgent Care, Houston, Texas, United States Centex-Houston, Houston, Texas, United States Accurate Clinical Management, LLC., Houston, Texas, United States BioPharma Clinc Site, Houston, Texas, United States Centex-Wesfield, Houston, Texas, United States B S & W Med Center, Irving, Texas, United States Zion Urgent Care Clinic, Katy, Texas, United States BioPharma Family Practice Center McAllen, McAllen, Texas, United States BRCR Medical Center, Inc, McAllen, Texas, United States North Hills Medical Research, North Richland Hills, Texas, United States Bay Area Infectious Diseases Associates, Pasadena, Texas, United States Epic Medical Research, Red Oak, Texas, United States Baylor - Round Rock, Round Rock, Texas, United States Sun Research Institute, San Antonio, Texas, United States Consano Clinical Research, LLC, Shavano Park, Texas, United States APD Clinical Research, Splendora, Texas, United States Baylor Scott and White Medical Center, Temple, Texas, United States Crossroads Clin Rch-Victoria, Victoria, Texas, United States CLS Research Ctr, PLLC, Webster, Texas, United States CARE ID, Annandale, Virginia, United States Virginia Commonwealth University, Richmond, Virginia, United States Evergreen Health Research, Kirkland, Washington, United States West Virginia University Hospital, Morgantown, West Virginia, United States Advanced Clinical Research, LLC, Bayamon, Puerto Rico Dorado Medical Complex Inc, Dorado, Puerto Rico GCM Medical Group, PSC - Hato Rey Site, San Juan, Puerto Rico |
|
| 2400 | Completed | A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff | SARS-CoV2 | Drug: LY3819253 Drug: Placebo Drug: LY3832479 |
Phase 3 | Eli Lilly and Company, National Institute of Allergy and Infectious Diseases (NIAID), AbCellera Biologics Inc., Shanghai Junshi Bioscience Co., Ltd. | INDUSTRY | 1374 | All | 18 Years | Unv of AL Sch of Med Div of Infectious Diseases, Birmingham, Alabama, United States Care Access Research, Phoenix, Arizona, United States Allergy and Asthma Clin of NW Ark, Bentonville, Arkansas, United States Care Access Research LLC, Huntington Beach, California, United States Alta Bates SMC, Oakland, California, United States University of Colorado-Anschultz Medical Campus, Aurora, Colorado, United States NIAID, Miami, Florida, United States NIAID, Decatur, Georgia, United States Belmont Village Lincoln Park, Lincoln Park, Illinois, United States Family Medicine, Indianapolis, Indiana, United States University of Louisville, Louisville, Kentucky, United States Care Access Rch Lake Charles, Lake Charles, Louisiana, United States Tulane University School of Medicine, New Orleans, Louisiana, United States NIAID - National Institute of Allergy & Infectious Diseases, Bethesda, Maryland, United States Care Access, Boston, Massachusetts, United States St. Paul IDA-CARe, Saint Paul, Minnesota, United States Care Access, Jackson, Mississippi, United States University of Mississippi Medical Center, Jackson, Mississippi, United States Children's Hospital & Medical Center, Omaha, Nebraska, United States Care Access Research - Bronx, Bronx, New York, United States NIAD, Chapel Hill, North Carolina, United States Valley Medical Primary Care, Centerville, Ohio, United States Univ of Cin College of Med, Cincinnati, Ohio, United States OSU Med Intl Med Houston Ctr, Tulsa, Oklahoma, United States Donahoe Manor, Bedford, Pennsylvania, United States Belmont Village, West Univ, Houston, Texas, United States Burke Internal Medicine and Research, Burke, Virginia, United States |
| 2399 | Completed | A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 | COVID-19 | Drug: LY3819253 Drug: Placebo |
Phase 1 | Eli Lilly and Company, AbCellera Biologics Inc. | INDUSTRY | 26 | All | 18 Years ~ 75 Years | Cedars Sinai Medical Center, Los Angeles, California, United States Veterans Affairs Medical Center San Diego, San Diego, California, United States Emory University, Atlanta, Georgia, United States Massachusetts General Hospital, Boston, Massachusetts, United States University of Massachusetts Medical Center, Worcester, Massachusetts, United States University of Michigan, Ann Arbor, Michigan, United States Quality Clinical Research, Inc., Omaha, Nebraska, United States Alexandria Center for Life - NYC/ NYCEDC, New York, New York, United States University of North Carolina, Chapel Hill, North Carolina, United States Unified Research Enterprise Brody School of Medicine at ECU, Greenville, North Carolina, United States Temple Univ School of Med, Philadelphia, Pennsylvania, United States |
| 2398 | Recruiting | A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19 | Hypoxemia | Drug: Ambrisentan Drug: Placebo |
Phase 2 | Noorik Biopharmaceuticals AG | INDUSTRY | 150 | All | 50 Years ~ 85 Years | Hospital Universitario de Cabuenes, Gijon, Asturias, Spain Hospital Universitario Virgen de las Nieves, Granada, Comunidad De Andalucia, Spain Hospital Universitario San Cecilio, Granada, Comunidad De Andalucia, Spain Hospital Universitario de Jaen, Jaen, Comunidad De Andalucia, Spain Hospital Universitario de Galdakao-Usansolo, Galdakao, Comunidad De Bizkaia, Spain Complejo Hospitalario de Navarra, Pamplona, Comunidad De Navarra, Spain Hospital Rey Juan Carlos, Mostoles, Madrid, Spain Hospital Universitario Infanta Leonor, Madrid, Spain University Hospital 12 de Octubre, Madrid, Spain Hospital Universitario La Paz, Madrid, Spain Hospital de Emergencias Enfermera Isabel Zendal, Madrid, Spain |
| 2397 | Active, not recruiting | A Study of N-acetylcysteine in Patients With COVID-19 Infection | Covid-19 | Drug: N-acetylcysteine Other: Peripheral Blood |
Phase 2 | Memorial Sloan Kettering Cancer Center | OTHER | 48 | All | 18 Years | Memorial Sloan Kettering Cancer Center, New York, New York, United States |
